baber/WOPTO huggingface dataset:
Patent NZ-588600-A (NZ)
Title: A controllable vacuum source having first and second vacuum pumps and an associated control system
Inventor: STELLNERT MATS
IPC: A01J5/007
Filed: 2005-06-20
Abstract: A vacuum source for providing vacuum to at least a first vacuum drain through conduits and a method for providing vacuum to a vacuum drain is disclosed. The vacuum source includes at least a first and a second vacuum pump and a control system. The control system is detects a consumed airflow and controls operation of the first and second vacuum pumps based on the detected consumed airflow.
Patent NZ-589883-A (NZ)
Title: Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy} quinazoline
Inventor: BOARDMAN KAY ALISON
IPC: A61K31/517
Filed: 2009-05-11
Abstract: Disclosed is the compound 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{ [1-(N-methylcarbamoylmethyl)piperidin-4-y 1]oxy} quinazoline difumarate.
Patent NZ-591451-A (NZ)
Title: Combustion powered fastener driving tool with back-pressure release holes
Inventor: ZHAO HANXIN
IPC: B25C1/14
Filed: 2009-08-07
Abstract: 591451 Disclosed is a combustion tool (10) including a cylinder (20) having a lower end provided with a resilient bumper (56), a piston (22) dimensioned for reciprocation within the cylinder to impact the bumper at an end of the cylinder and having a driver blade (24) depending therefrom for impacting fasteners. At least one back pressure release opening (66) is disposed in the cylinder to be in alignment with the piston and to be closed by the piston when the piston impacts the bumper.
Patent NZ-592156-A (NZ)
Title: METHOD FOR PRODUCING DESALTED MILK, AND DESALTED MILK using anion exchange separation process and nanofiltration
Inventor: SEKI NOBUO
IPC: A23C9/142
Filed: 2010-03-30
Abstract: Disclosed is a process for producing a demineralized milk, the process comprising: passing a raw milk through an anion exchange resin in chloride form to effect anion exchange, and removing monovalent minerals contained within said raw milk following said anion exchange using a membrane separation process.
Patent NZ-592867-A (NZ)
Title: Compositions and methods for inhibiting expression of transthyretin
Inventor: SAH DINAH WEN-YEE
IPC: A61K31/713
Filed: 2009-10-20
Abstract: Disclosed is a double-stranded ribonucleic acid (dsRNA) for inhibiting expression of transthyretin (TTR). The dsRNA comprises a sense strand and an antisense strand, the antisense strand comprising a region complementary to a part of a mRNA encoding transthyretin (TTR), wherein said region of complementarity is 19 nucleotides in length, the antisense strand comprises SEQ ID NO: 170 as defined in the complete specification, and each strand of the dsRNA is 19, 20, 21, 22, 23 or 24 nucleotides in length.
Patent NZ-595010-A (NZ)
Title: Filler composition for use in the papermaking process
Inventor: SIMONSON PATRIK
IPC: C08L1/28
Filed: 2008-07-14
Abstract: Disclosed is a filler composition comprising:(a) a filler,(b) cationic organic polymer selected from a cationic polyamine, cationic polyamideamine, cationic polyethylene imine, cationic dicyandiamide polymer, cationic acrylamide-based polymer, cationic acrylate-based polymer, cationic vinylamine / vinylformamide-based polymer or cationic polymer based on diallyl dialkyl ammonium chloride, and(c) an anionic polysaccharide,wherein the filler is present in an amount of at least about 1 % by weight, based on the total weight of the composition, the cationic inorganic compound is present in an amount of up to about 30 kg/ton, based on the weight of filler, and the anionic polysaccharide has a degree of substitution of net anionic groups of up to about 0.65. The disclosure further relates to a method of preparing a filler composition comprising mixing the components (a), (b) and (c) as defined above. The disclosure also relates to a filler composition obtained by the method, use of a filler composition as an additive to an aqueous cellulosic suspension in a papermaking process, and a process of producing paper comprising adding the filler composition to an aqueous cellulosic suspension; and to paper comprising the filler composition obtained by said papermaking process.
Patent NZ-599397-A (NZ)
Title: Phase-shifted center-distance diffractive design for ocular implant
Inventor: HONG XIN
IPC: A61F2/16
Filed: 2010-10-22
Abstract: A diffractive multifocal design for ocular implant is provided. This ocular implant includes a diffractive multifocal intraocular lens (IOL) and a plurality of haptics. The diffractive multifocal IOL passes optical energy to distance, intermediate and near foci. The haptics mechanically couple to the diffractive multifocal IOL in order to position and secure the diffractive multifocal IOL within the eye. The diffractive multifocal IOL may include both a diffractive region and a refractive region, the diffractive multifocal IOL operable to phase shift optical energy such that constructive interference occurs within the diffractive region and the refractive region. The diffractive multifocal IOL has a thin edge having a thickness of 0.6mm or less, which advantageously allows for a small incision during implantation.
Patent NZ-599456-A (NZ)
Title: Assays for the detection of anti-tnf drugs and autoantibodies
Inventor: SINGH SHARAT
IPC: G01N33/50
Filed: 2010-10-26
Abstract: Disclosed is a method for determining the presence or level of an anti-TNFαlpha drug in a sample, the method comprising: (a) contacting a labelled TNFαlpha with a sample having an anti-TNFαlpha drug to form a labelled complex with the anti-TNFαlpha drug; (b) subjecting the labelled complex to size exclusion chromatography to separate the labelled complex from free labelled TNFαlpha and to detect an amount of the labelled complex and an amount of the free labelled TNFαlpha; and (c) comparing the amount of the labelled complex and the amount of the free labelled TNFαlpha detected in step (b) to a standard curve of known amounts of the anti-TNFαlpha drug, thereby determining the presence or level of the anti-TNFαlpha drug.
Patent NZ-601383-A (NZ)
Title: Methods and compositions for improved nerve conduction velocity
Inventor: MCCARTHY THOMAS DAVID
IPC: A61P25/02
Filed: 2011-01-19
Abstract: The disclosure relates to a use of a selective AT2 receptor antagonist compound of formula (I) in the manufacture of a medicament for the effective treatment of impaired nerve signal conduction, wherein the variables are as defined in the specification. Also disclosed are compositions including selective AT2 receptor antagonists as active agents that are suitable for use in relation to improving nerve signal conduction or reversing impaired nerve signal conduction.
Patent NZ-602524-A (NZ)
Title: A simulated cigarette
Inventor: HEARN ALEX
IPC: A24F42/60
Filed: 2011-03-23
Abstract: A simulated cigarette which has a housing with a generally cigarette-like shape and size, a reservoir of inhalable composition within the housing; a means for controlling the flow from the reservoir and an outlet passage from the means for controlling the flow from the reservoir to an outlet in the housing from which outlet a user inhales the composition. The housing is wrapped in a wrap comprising an adhesive layer to stick to the housing, a paper or paper-like layer to provide a more realistic feel, and a polymer film to cover and protect the paper or paper-like layer.
Patent NZ-602589-A (NZ)
Title: Jacket structure for offshore constructions
Inventor: STIESDAL HENRIK
IPC: E02D27/42
Filed: 2010-09-15
Abstract: Disclosed is jacket structure for offshore wind turbines. The jacket structure comprises a number of first and second profiles; a number of node members (4) and at least one adapter profile (9). The jacket structure provides a stable connection and a less complex method of connecting profiles and node members (4) and allows a wider choice of materials for construction of the jacket structure. The first profiles comprise rods in axial alignment. The second profiles comprise rods in angled alignment relative to the first profiles. The node members (4) provide a connection for the second profiles. The node members (4) are connected to the first profiles and/or at least an adapter profile (9) by means of a bolted connection (8). The jacket structure comprises anti-corrosive material(s) and/or coating(s).
Patent NZ-602665-A (NZ)
Title: Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihyderoxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
Inventor: ZHANG BEILI
IPC: C07D405/12
Filed: 2011-03-25
Abstract: The present disclosure relates to solid forms of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2- methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1, VX-661) in substantially crystalline form (Form A) or amorphous form, pharmaceutical compositions thereof, and methods of treatment therewith.
Patent NZ-602920-A (NZ)
Title: Kras primers and probes
Inventor: STEPHENS CRAIG
IPC: C12Q1/68
Filed: 2011-04-12
Abstract: Disclosed is an oligonucleotide consisting of a nucleotide sequence of GTCAAGGCACTCTTGCCTAAGT (SEQ ID NO:1) or an oligonucleotide substantially identical thereto, wherein the substantially identical oligonucleotide has at least 90% sequence identity with the oligonucleotide of SEQ ID NO:1, and wherein there is no mismatch in the five nucleotides at the 3’ end. Further disclosed are methods of detecting KRAS mutations using said reverse primer and the forward primer consisting the nucleotide sequence GGCCTGCTGAAAATGACTGA (SEQ ID NO: 2) for detecting a mutation in codon 13 in exon 2 of the KRAS gene.
Patent NZ-605561-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: ANDERBERG JOSEPH
IPC: G01N33/92
Filed: 2011-06-23
Abstract: A method for evaluating renal status in a subject ex vivo, comprises performing one or more assays configured to detect one or more biomarkers present in a body fluid sample obtained previously from the subject where at least one biomarker is Apolipoprotein E; determining on the body fluid sample one or more assay result(s); and correlating the assay result(s) to the renal status of the subject/. The correlating comprises comparing a measured concentration of Apolipoprotein E to a threshold concentration of Apolipotein E and assigning a likelihood of an event occurring or assigning a likelihood of an event occurring when the measured concentration varies from the threshold.
Patent NZ-610581-A (NZ)
Title: Bioprocessing
Inventor: MEDOFF MARSHALL
IPC: C12M3/00
Filed: 2010-05-18
Abstract: Disclosed is a method for producing a fermented product comprising: providing a pre-functionalised inorganic substrate wherein the inorganic substrate is pre-functionalised by ionising the inorganic substrate then quenching the inorganic substrate with a quenching liquid or gas; and fermenting the pre-functionalised inorganic substrate in a fermentation system; wherein the fermentation system comprises a substrate delivery system for delivering the pre-functionalised inorganic substrate to an organism and to a fermentation tank, wherein the organism becomes immobilised on the pre-functionalised inorganic substrate and ferments sucrose, glucose, xylose or a mixture of these in the fermentation tank to produce the fermented product, and wherein the fermentation system does not contain a functionalising module that is capable of functionalising an inorganic substrate by ionising and quenching.
Patent NZ-628801-A (NZ)
Title: Drive assembly and exercise apparatus including a drive assembly
Inventor: THOMAS WILLIAM HENRY
IPC: B62K17/00
Filed: 2013-01-21
Abstract: A drive assembly converts the motion of a person running or jogging into mechanical motion to drive a machine or apparatus, such as self-propelled apparatus like a bicycle, or stationary exercise apparatus. The drive assembly comprises a rotatable member, such as a sprocket crank arrangement 17, coupled to a frame of the machine and to stirrups 22, and where foot pedals 26 are pivotally attached to each of the stirrups. A first pivot 24 is connected between a stirrup 22 and the rotatable member 17, and a second pivot 23 is connected between the same stirrup 22 and the frame 14. In use the pivot axes 25 of the foot pedals travels both in front of and behind a rearward position of the second pivots 23, and the second pivots 23 follows a substantially forward and upward and downward and backward reciprocating path 71 relative to the frame. The pivots 23 may be running on a slide along axis 14 or mounted on one the end of a long link attached at the other end to the frame. Preferably, a pivot axis 25 of a foot pedal remains below the first pivot and the second pivot during motion of the foot pedal. Preferably, the pivot axes of the foot pedals trace asymmetric ovate paths during motion of the foot pedals.
Patent NZ-707438-A (NZ)
Title: A cap with toy device
Inventor: TAMARINDO STEFANO
IPC: B65D51/28
Filed: 2013-11-18
Abstract: Often it is difficult to get children to voluntarily consume liquids or semi-solids. One approach is to serve the liquid or semi-solid in a novelty package such as a painted or themed container. However children may get bored of such containers. To address this potential loss of interest, and to excite children the present invention provides a cap with guarantee seal (14) for flexible packages which has a toy compartment (22, 44) and a ball (42) free to move by agitation of the cap, in the toy compartment (22, 44). Passages (55) are made between the toy compartment (44) and the inner compartment (22), and wherein the toy element (42) has dimensions such as not to be suitable to traverse the passage (55) from the toy compartment (44) to the inner compartment (22). This serves to engage the interest of the consumer, whilst safely being able to dispense the product without obstruction.
Patent NZ-713602-A (NZ)
Title: Method for refining protein including self-cutting cassette and use thereof
Inventor: YUN JEE SUN
IPC: C12N15/70
Filed: 2014-04-25
Abstract: The present invention relates to a self-cleaving fusion protein including a target protein, a peptide consisting of amino acid sequence represented by LPXTG, a domain of Sortase A having cleaving function, and a tag, which are sequentially positioned from the amino terminal; a nucleic acid encoding the same; an expression vector including the nucleic acid of the present invention; and a cell transformed with the expression vector of the present invention. In addition, the present invention relates to a method for refining a target protein including culturing, dissolving, and purifying the transformed cell, and a method for preparing a therapeutic antibody-drug conjugate by using the purifying method.
Patent NZ-717586-A (NZ)
Title: Pyridazinone compounds and uses thereof
Inventor: BEIGELMAN LEONID
IPC: C07D498/22
Filed: 2014-09-10
Abstract: Disclosed herein are pyridazinone compounds, pharmaceutical compositions that include one or more pyridazinone compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an orthomyxovirus infection, with a pyridazinone compounds. Examples of an orthomyxovirus viral infection includes an influenza infection.
Patent NZ-719414-A (NZ)
Title: High protein denatured whey protein composition, related products, method of production and uses thereof
Inventor: BERTELSEN HANS
IPC: A23J1/20
Filed: 2014-10-23
Abstract: The present invention pertains to a new type of denatured whey protein compositions having a low content of soluble whey protein and a high content of protein and to a method of producing them. In particular, the present invention pertains to the new type of denatured whey protein compositions having a low content of soluble whey protein, a high content of protein and low content of fat and to a method of producing them. The invention furthermore pertains to products containing the high protein denatured whey protein compositions, particularly high protein, acidified dairy products, and additional uses thereof.
Patent NZ-726360-A (NZ)
Title: Phosphatidylinositol 3-kinase inhibitors
Inventor: PHILLIPS BARTON
IPC: C07D513/04
Filed: 2015-06-10
Abstract: The present application provides the compounds of formula (J), or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein n, W, A’, B’, R1, R2, and R3 are described herein. The compounds are inhibitors to the activities of phosphatidylinositol 3-kinase (PI3K) and are useful for treating conditions mediated by one or more PI3K isoforms. The present application further provides pharmaceutical compositions that include a compound of formula (I), or pharmaceutically acceptable salts, isomers, tautomer, or mixture thereof, and methods of using these compounds and compositions for treating conditions mediated by one or more PI3K isoforms.
Patent NZ-726895-A (NZ)
Title: Ex vivo organ care system
Inventor: HASSANEIN WALEED
IPC: A01N1/02
Filed: 2015-06-02
Abstract: A perfusion circuit including: a pump for providing a pulsatile fluid flow of a perfusion fluid; a gas exchanger; a divider configured to divide the perfusion fluid into a first branch and a second branch, wherein the first branch comprises a hepatic artery interface and is configured to provide a first portion of the perfusion fluid to a hepatic artery of the liver, wherein the second branch comprises a portal vein interface and is configured to provide a second portion of the perfusion fluid to a portal vein of the liver; the second branch comprising a clamp configured to control flow rate of the perfusion fluid; the second branch comprising a compliance chamber configured to reduce a pulsatile flow characteristic of the perfusion fluid; a drain to receive the perfusion fluid from an inferior vena cava of the liver; and a reservoir to receive the perfusion fluid from the drain. This extends the time during which an organ can be preserved in a healthy state ex-vivio.
Patent NZ-739849-A (NZ)
Title: Solid agrochemical compositions
Inventor: TALATI PARESH
IPC: A01N25/12
Filed: 2016-07-30
Abstract: A storage stable non-hygroscopic granular compositions comprising 20 % to about 70 % glufosinate or a salt thereof; and at least two surfactants selected from an amine, an alkoxylated fatty alcohol and an alkylated vegetable oil. Amine is present in an amount of about 0.1% to about 30% by weight of the composition and is selected from the group consisting of ethylene diamine, trimethylene diamine, tetramethylenediamine, diethylenetriamine, triethylenetetramine, N-hydroxyethylethylenediamine, hexamethylenediamine, hexadecylamine and hexamethylenetetramine. The alkoxylated fatty alcohol is present in an amount of about 0.1% to about 20 % by weight of the composition, and comprises a fatty alcohol comprising alkyl groups having about 5 to about 20 carbon atoms, and an alkoxylate comprising from about 3 moles to about 15 moles of ethylene oxide and/or propylene oxide. The alkylated vegetable oil is present in an amount of about 1% to about 20 % by weight of the composition, and is selected from the group consisting of methylated corn oil, methylated linseed oil, methylated soybean oil, methylated rapeseed oil, methylated cotton seed oil and methylated sunflower oil.
Patent NZ-751593-A (NZ)
Title: Display system and method
Inventor: SCHOWENGERDT BRIAN T
IPC: H04N13/398
Filed: 2014-03-14
Abstract: Disclosed is a method of displaying a sequence of frames comprising image data representing virtual content at a frame rate to a user via a virtual or augmented reality system. The method includes rendering a first complete frame comprising the image data having at least a first field formed by a first scanning motion, storing at least the first complete frame on a frame buffer, and retrieving at least a first portion of the first complete frame from the frame buffer. The first field is generated by projecting light beams corresponding to the first portion in the first scan pattern by one or more optical fibers. A head movement of a user is predicted in excess of a nominal head movement value, and an updated complete first frame is determined based on the predicted head movement. The updated complete first frame is rendered which comprises at least a subsequent portion to the first portion and the subsequent portion comprising an updated first field formed by a second scanning motion. The updated complete first frame is stored to the frame buffer, and at least the subsequent portion of the updated complete first frame is retrieved from the frame buffer. The generation of the first field is interrupted in its entirety before completion of the first complete frame. At least the subsequent portion of the updated complete first frame is generated by projecting light beams corresponding to the updated first field by the one or more optical fibers.
Patent NZ-770002-A (NZ)
Title: Nasal mask system
Inventor: GUNEY MEMDUH
IPC: A62B9/00
Filed: 2012-11-15
Abstract: A patient interface including (i) a nasal mask and (ii) a positioning and stabilising structure including a pair of side straps. The nasal mask includes a seal forming structure and a plenum chamber (150). The seal forming structure includes a sealing flange (160) to seal on a portion of a patient’s upper lip and on a portion of the nose. The plenum chamber is pressurizable to above ambient air pressure, is adapted to receive the pronasale, and includes an attachment region (158) to fluidly couple to an air delivery system. The plenum chamber includes a side wall region (157) extending between the seal forming structure and the attachment region. The seal forming structure and the plenum chamber comprise a one piece molded construction, and is made of a flexible elastomeric material. The nasal mask includes a pair of headgear connectors (156) disposed on respective sides of the side wall region and integrally formed as part of the one piece molded construction. The side straps connect to the headgear connectors, providing a two-point connection to the nasal mask. The positioning and stabilizing structure is constructed and arranged to be donned or removed without the pair of side straps passing inferior to the patient’s ears.
Patent PT-101625-A (PT)
Title: Improvements to carriages (gantries, frames, portals) for automated welding of panels
Inventor: SANTOS JOSE FRANCISCO DE OLIVE
IPC: B23K37/00
Filed: 1994-12-23
Abstract: The aim of the carriage and respective equipment is to form panels by butt welding of steel sheets. Welding of the sheets is carried out by means of one-side welding (OSW), in the low position, it being unnecessary, however, to turn the panel subsequently to conclude welding. The welding process uses the submerged arc system with the placing of appropriate flux on both sides of the joint. On the underside, use is made of a flexible cover plate on which the welding flux is deposited. They are essentially characterized by a beam 3 which supports the cover plate to be secured with one of the lower sheet- holding beams, by the automatic system 10 for placing the flux on the cover plate utilizing a worm for lifting and transporting the flux and moving autonomously, having recourse to electric motorization, and the horizontal guide device 11 of the contact probe belonging to the automatic system for following (monitoring) the joint. <IMAGE>